Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
In patients with advanced ICC, the timely initiation of ICIs as adjuvant therapy following first-line antitumor treatment can result in favorable efficacy and a good safety profile.
Authors
- Shuyao Tang
- Jianhui Dong
- Jian Shi (ORCID: https://orcid.org/0000-0002-1659-6609)
- Tongdong Shi
- Ziting Peng
Institutions
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.3389/fonc.2025.1498887
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Chongqing Medical University